September 24, 2022
The deputy director of the Masonic Cancer Center discussed trends of presentations from ESMO 2022.
September 20, 2022
The deputy director of the Masonic Cancer Center discussed the preclinical findings of his study on a TriKE engager and NK cells.
July 07, 2022
The professor of medicine and University of Minnesota Medical School discussed the advantages and unmet needs of natural killer cells in oncology.